Healthcare -
Biotechnology - NASDAQ - US
$ 0.2024
-15.7 %
$ 3.71 M
Market Cap
-0.03
P/E
VRPX - STOCK-BASED COMPENSATION
Stock-based Compensation VRPX - Virpax Pharmaceuticals, Inc.
545 K
LAST VALUE
-25.22%
2 YEAR CAGR
7.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR